Hallucinations and Delusions Associated with Alzheimer’s Disease Psychosis research hub

An Open-Label Study to Assess the Long-Term Safety and Tolerability of ML-007C-MA in Adult Participants with Hallucinations and Delusions Associated with Alzheimer’s Disease Psychosis

This study looks at a new drug, ML-007C-MA, over a long time to see how safe it is and if people can tolerate it. It's for adults with Alzheimer's disease who experience hallucinations and delusions. The main goal is to check for any side effects.